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Background: Polar development during the alphaproteobacterium Caulobacter crescentus cell cycle is integrated to
the point that individual mutations can have pleiotropic effects on the synthesis of polar organelles. Disruption of
the genes encoding the histidine kinase PleC, or its localization factor PodJ, disrupts synthesis or functionality of pili,
flagella and adhesive holdfast. However, the mechanism by which these mutations affect polar development is not
well understood. The aim of this study was to identify new regulators that control multiple aspects of polar
organelle development.
Results: To identify mutants with pleiotropic polar organelle synthesis defects, transposon mutagenesis was
performed and mutants were selected based resistance to the pili-tropic bacteriophage ΦCbK. Mutants were then
screened for defects in motility and holdfast production. Only a single podJ/pleC-independent mutant was isolated
which had defects in all three phenotypes. Directed phage assays confirmed the phage resistance phenotype, while
the strain demonstrated a similar dispersal radius as a podJ mutant in swarm agar, and treatment with a fluorescent
lectin that labels the holdfast showed no staining for this mutant. The transposon had inserted into the promoter
region of ctrA, a gene encoding a master transcriptional regulator of the cell cycle, disrupting native transcription
but still allowing reduced transcriptional activity and protein production of this essential protein. Transcriptional
fusions showed that essential genes controlled by CtrA exhibited minor to moderate changes in expression in the
ctrA promoter mutant, while the pilA gene, encoding the subunit of the pilus filament, had a drastic decrease in
gene expression. Introduction of a plasmid-born copy of ctrA under its native promoter complemented the phage
resistance and holdfast defects, as well as a moderate cell morphology defect, but not the swarming defect.
Conclusions: A mutation was identified that caused pleiotropic defects in polar organelle synthesis, and revealed
the surprising result that some CtrA-dependent promoters are more sensitive to changes in CtrA concentration
than others. However, the fact that no pleiotropic mutations were found in new regulators suggests that
downstream signaling of PleC/PodJ is either essential, redundant, or branching such that all three phenotypes were
not simultaneously affected.
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The best-studied asymmetrically dividing prokaryote is
the alphaproteobacterium Caulobacter crescentus. At
each cell division, predivisional cells of C. crescentus
localize different structures at the cell poles: a single fla-
gellum occupies the pole that will be inherited by the
swarmer cell and pili are synthesized at this pole after
division, whereas a narrow extension of the cell envelope
(the stalk) tipped by an adhesive structure (the holdfast)
occupies the opposite pole that will give rise to the
stalked cell. The stalked cell is able to restart the cell
cycle immediately after division, whereas the swarmer
cell is unable to initiate DNA replication until it differ-
entiates into a stalked cell.
The C. crescentus cell cycle and developmental program
are controlled by three master regulators: CtrA, GcrA,
and DnaA (for review, see [1]). These proteins are regu-
lated such that each one reaches maximal abundance dur-
ing a different stage of the cell cycle. DnaA reaches peak
abundance at initiation of DNA replication occurring in
stalked cells, GcrA peaks after DNA replication in early
predivisional cells, and CtrA peaks in late predivisional
and swarmer stages [2]. All three proteins are required for
regulating transcription of different suites of genes. DnaA
activates genes involved in chromosome partitioning, nu-
cleotide biosynthesis, and DNA replication, recombination
and repair [3], and initiates replication of the chromo-
some. DnaA is also required for transcription of gcrA [3].
GcrA activates transcription of genes involved in DNA
replication, recombination and repair different from DnaA
targets [3-5]. GcrA also activates genes required for polar
development (including pleC and podJ, both of which are
also activated by DnaA [3,4]). CtrA, in turn, regulates at
least 95 genes in 55 operons: some are repressed (for ex-
ample gcrA and podJ [4,6]) whereas others are activated
(such as the pilin subunit gene pilA, flagellum synthesis
cascade initiation, and the holdfast anchor operon [7]).
Additionally, CtrA binds to the chromosome at the origin
of replication where it represses the initiation of DNA rep-
lication [8]. Furthermore, CtrA both activates and re-
presses its own promoters.
The ctrA gene has two promoters: P1 and P2 [9]. The
weaker upstream P1 promoter is activated first. P1
activation requires that the promoter be in the hemi-
methylated state, meaning that DNA replication has
initiated and the replication fork has passed the P1 pro-
moter. The P1 promoter is also directly activated by
GcrA [4,9,10]. The low level of expression from the
GcrA-activated ctrA P1 promoter allows some CtrA
protein to accumulate. Once sufficient CtrA has accu-
mulated, it represses the P1 promoter (as well as gcrA
expression) and activates the strong downstream P2
promoter [9], leading to a burst of CtrA production and
activity.The sequential activation of the master regulators
forms the timeline by which developmental processes
are regulated and coordinated. In particular, GcrA con-
tributes to the expression of the key developmental reg-
ulators, the histidine kinase PleC and the polar
localization factor PodJ. Loss of either protein causes
pleiotropic defects in development. A pleC mutant does
not synthesize a stalk, holdfast or pili, and though the
flagellum is made, flagellar rotation is not activated and
the flagellum is not shed during the swarmer cell differ-
entiation [11-13]. A podJ mutant, like pleC, does not
synthesize holdfast or pili or shed its flagellum, but it
does synthesize a stalk and activates its flagellum, how-
ever its motility is impaired in low-percentage agar as
compared to wild type [6,14,15].
To further elucidate the pathways that lead to these
pleiotropic phenotypes a genetic approach was used. We
conducted a transposon mutagenesis screen, selecting for
resistance to phage ΦCbK, which requires pili for infec-
tion, and screening for defects in motility and adhesion,
which require the flagellum and holdfast respectively. In
this work we report the identification of a transposon in-
sertion in the promoter region of ctrA that causes a drastic
reduction of CtrA accumulation, resulting in pleiotropic
phenotypes bearing similarities to the pleC and podJ
phenotypes.Results and discussion
A transposon mutation causes a pleiotropic phenotype
C. crescentus wild-type strain CB15 was mutagenized with
the mariner transposon and mutants resistant to the bac-
teriophage ΦCbK were isolated to enrich for mutants de-
fective in pilus synthesis. Once isolated, mutants were
microscopically examined to identify defects in the pres-
ence or placement of stalks, the formation of rosettes
(groups of cells adhered to each other by their holdfasts),
or in swimming motility. Strains exhibiting a defect in any
of these features were further analyzed for motility defects
on swarm plates. A total of 330 KanR ΦCbKR mutants
were screened and classified into 7 categories (A-G) based
on these polar phenotypes (Table 1). The majority of mu-
tants (297) were morphologically indistinguishable from
wild-type when grown in PYE liquid media (Class A),
suggesting that they were pili synthesis mutants; these
were not analyzed further. Classes B, C and D had stalks,
formed rosettes, and differed from each other only in their
swarming phenotype, ranging from no swarming (Class B)
to the formation of small swarms (Class C) and finally to
moderate-sized swarms resembling those of a podJ mutant
(Class D). Class E exhibited phenotypes identical to a podJ
mutant (stalks, no rosettes and moderate swarming), and
all were confirmed by Southern analysis to have insertions
in podJ. Class F resembled the known pleC phenotype
Table 1 Classes of ΦCbK-resistant mutants isolated
# of mutants Stalksa Rosettesa Swimminga Swarmingb
Wild-type Control + + + ++++
ΔpodJ Control + - + ++
ΔpleC Control - - - +
Class A 297 + + + ND
Class B 5 + + - -
Class C 3 + + - +
Class D 3 + + - ++
Class E (podJ) 8 + - + ++
Class F (pleC) 13 +/− - + +
Class G (YB3558) 1 +/− +/− + +++
aDetermined by visual identification in liquid culture. bDetermined by assaying motility of cells through low-percentage agar. Phenotypes scored on a relative
scale from fully motile (++++) to non-motile (−). ND = not determined.
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class were shown to have insertions in pleC.
One mutant, M134 and later the transduced derivative
YB3558, did not fit into any of the other classes. Similar to
podJmutants, this mutant produces moderate sized swarms
(Figure 1), yet the morphology of the cells was variable and
did not resemble podJ mutant cells which exhibit normal
morphology. Analysis of the cell morphology of YB3558 re-
vealed that it had numerous deficiencies as compared to
wild-type CB15 (Figures 2 and 3). Cells displayed a moder-
ate filamentation phenotype. A cell division defect was ap-
parent in an increased percentage of cells with at least one
visible constriction. In CB15 predivisional cells comprisedFigure 1 Motility of YB3558, YB3559 and ctrA401. The swarm
assay was performed as described in the Methods. The non-motile
rpoN mutant and the polar development mutant ΔpodJ are
included. YB3558 displays an intermediate swarming defect,
between ΔpodJ and wild-type levels, similar to a ctrA temperature
sensitive lethal allele grown under permissive conditions.
Complementation of YB3558 with a wild-type ctrA gene under
native control (YB3559) does not restore the swarming phenotype.17% of the total population, whereas in YB3558, 35% of the
population was had at least one constriction. Furthermore,
the prevalence of cells with multiple constrictions was
increased from less than 1% in CB15 to 3% of the total cell
population (or ~10% of predivisional cells) in YB3558.
More severe defects were observed in stalk synthesis
(Figures 2 and 3). In CB15, 91% of predivisional cellsFigure 2 Morphology of YB3558 and YB3559. Phase micrographs
of exponentially growing cultures of CB15, YB3558, ctrA401 and
YB3559 at 30°C. YB3558 displays increased filamentation, increased
percentage of cells with multiple constrictions, and a stalkless
phenotype. These defects are also seen in the ctrA temperature
sensitive strain grown under permissive conditions.
Complementation of YB3558 with a wild-type ctrA gene under
native control (YB3559) restores cell morphology to that
of wild-type.
Figure 3 Lectin binding of wild-type CB15, YB3558 and YB3559. Wild-type, YB3558 and YB3559 cells were treated with FITC-conjugated
WGA lectin and imaged as described in the Methods. WGA lectin binds to holdfast and is seen as a fluorescent focus when imaged (example
indicated with white arrow, WT panel). Wild-type cells display holdfast at the tips of stalks, while the YB3558 mutant produces no holdfast.
Complementation of YB3558 with a ctrA gene under native control (YB3559) restores holdfast synthesis.
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Staining of holdfast polysaccharide with FITC-WGA indi-
cated that 8% of predivisional cells of YB3558 had a hold-
fast as compared to 74% of predivisional CB15 cells
(Figure 3).
YB3558 demonstrated similar phage resistance to ΦCbK
as podJ in a phage sensitivity assay. When serial dilutions
of cells were mixed with phage stock and spotted on PYE
plates (Figure 4), cell growth in lower dilutions was slightly
less dense than that of the fully resistant podJ mutant.
However, relative to wild-type cells, YB3558 exhibitedFigure 4 Phage resistance of YB3558 and YB3559. Resistance to
the Caulobacter phage ΦCbK was assayed as described in the
Methods. Dilutions of cells were mixed with phage stock and
spotted onto PYE plates. CB15 is sensitive to the phage, ΔpodJ is
resistant, and YB3558 shows virtually the same phage resistance as
ΔpodJ. Complementation with ctrA under native control (YB3559)
decreases phage resistance to nearly wild-type levels.significant phage resistance, allowing survival at the lower
dilutions of phage. Finally, YB3558 grew more slowly than
wild-type with a doubling time of 123 minutes as com-
pared to 97 minutes (Figure 5).
YB3558 transposon insertion is in the ctrA regulatory
region
Mapping of the mutation in YB3558 indicated that the
transposon had inserted between the −10 and −35 sites of
the ctrA P2 promoter (Figure 6A) [9], indicating that the
pleitropic defects observed are not due to disruption of a
polar development gene like podJ or pleC, but alteration
of one of the master regulators directly. The exact site of
insertion and the sequence of the end of the transposon
were such that the −35 site remained somewhat intact. Of
the two TTAA half-sites required for CtrA-binding [9],
one was slightly altered (TTAA→TTAT), and the other
was completely abolished (Figure 6A). The half site that
was completely abolished is very likely necessary for effi-
cient transcription of CtrA-controlled promoters, includ-
ing ctrA itself. While the end of the transposon creates
another half site, it is separated by an additional 5 bases
from the first half site. Previous mutational analysis of the
consensus CtrA recognition sequence revealed that the
drastic alteration of either TTAA half site in the recogni-
tion sequence TTAA-n7-TTAA greatly reduces transcrip-
tion of the promoter, and alteration of the downstream
TTAA half site can also abolish cell-cycle regulation [16].
Because YB3558 does not have the complete recognition
site essential for efficient induction of the P2 promoter by
CtrA, and the P1 promoter is separated from the transla-
tional start site by the full length of the transposon, we hy-
pothesized that transcription of the ctrA gene is reduced
in the YB3558 mutant, and the resultant reduction of CtrA
protein could be the cause of the pleiotropic phenotypes
observed in this strain.
To verify this hypothesis, we generated a fusion of the
ctrA mutant promoter from YB3558 to lacZ and com-
pared expression from this promoter to the wild-type ctrA
Figure 5 Growth rate of YB3558 and YB3559. Growth curves of CB15 (black diamonds), YB3558 (open squares) and YB3559 (black squares).
YB3558 shows slower growth than wild-type. Complementation with ctrA under native control (YB3559) restores wild-type growth.
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growth (Figure 6B). Expression from the mutant promoter
was only 20% of wild-type ctrA promoter expression in
YB3558 and 29% wild-type ctrA promoter expression in
the wild-type strain indicating that even when CtrA is
present and its activity is normal (as it is in CB15), the
mutant promoter is not efficiently transcribed.
Since the mutant ctrA promoter (containing the trans-
poson insertion) from YB3558 demonstrated reduced ac-
tivity in wild-type, suggesting ctrA transcription is reduced
in YB3558, Western blot analysis was performed to
measure CtrA abundance. Results showed that CtrA is
expressed at a much lower level in YB3558 than in CB15
(Figure 6C). Subsequent quantification of band intensities
from six Western blots showed that CtrA is present at ap-
proximately 22 +/− 5% of the wild-type CB15 level, dem-
onstrating that the reduced transcription resulting from
the transposon insertion leads to drastically lower CtrA
protein levels.
Polar development defects are linked to altered CtrA
abundance/activity
In order to determine if the lower CtrA levels are in-
volved in the polar development defects found in
YB3558, similar assays that were performed on YB3558
were also performed on ctrA401, a temperature sensitive
CtrA allele [17]. At the restrictive temperature the allele
is lethal, but at the permissive temperature ctrA-
dependent promoters demonstrate altered transcription
patterns that indicate that CtrA401 has impaired func-
tion. Phenotypic analysis demonstrates that a ctrA401
mutant has a reduced swarming phenotype (Figure 1), as
well as morphological defects (Figure 2), both of which
mirror those of YB3558.Plasmid pSAL14 was introduced into YB3558, creating
strain YB3559. pSAL14 is a low copy plasmid carrying a
copy of the ctrA gene with its native promoter [17].
Introduction of the plasmid restored CtrA production to
slightly above wild-type levels (Figure 6C). Phenotypic
analysis of YB3559 demonstrated that ctrA complemen-
tation restores cell morphology (Figure 2) and holdfast
synthesis (Figure 3) to wild-type phenotypes, and growth
rate to near wild-type levels (Figure 5). Phage sensitivity
was increased over that of the parent YB3558 (Figure 4),
but not complemented to full wild-type levels (it should
be noted pinprick-sized colonies are likely spontaneous
suppressors). Interestingly, ctrA complementation ap-
pears to have no effect on the swarming defect of
YB3558 (Figure 1). The causal relationship between re-
duced CtrA abundance and the reduced swarming
phenotype in this mutant is unknown.
Effect of the ctrA promoter mutation on transcription of
developmentally regulated genes
Though expression of the mutant ctrA promoter was re-
duced regardless of the strain harboring it (Figure 6B),
the wild-type ctrA promoter displayed similar expres-
sion levels when placed in YB3558, indicating its activity
is resistant to the severe reduction in CtrA protein
levels in that strain. Given that CtrA is a global regula-
tory protein for both essential (e.g. cell division) and
non-essential (e.g. polar development) genes, and that
the drastic CtrA reduction in YB3558 leads to polar de-
velopmental defects but the strain is still viable, we
hypothesized that transcription of CtrA-regulated genes
essential for cell survival will be less affected by CtrA
reduction in YB3558 than those that are essential for
less important cellular functions. Thus we investigated
Figure 6 Insertion site of the transposon in YB3558 and effect on CtrA abundance. A) Location of the insertion site relative to the P1 and
P2 promoters of ctrA and sequence of the wild-type ctrA P2 promoter and the mutated ctrAP2::Mn promoter. Shaded boxes indicate CtrA
recognition sequence half sites. Transcription start site is indicated [9]. Triangle indicates site of transposon insertion. Transposon sequence is
underlined. B) Expression of wild-type (pctrA290) and mutant (pctrAP2::Mn) ctrA promoters in wild-type and YB3558 strains. β-galactosidase assays
were performed on exponentially growing cultures as described in the Methods (absorbance measurements for this experiment were carried out
on a Nanodrop 2000 (Thermo Scientific) with a 0.1 mm light path and therefore activities are not Miller Units, and instead have been labeled β-
galactosidase Activity). The mutant promoter displays a large reduction in activity compared to the wild-type promoter in both CB15 and YB3558.
The wild-type promoter displays an expression level in YB3558 similar to that in CB15. C) Western Analysis of CtrA abundance in YB3558 and
YB3559. Western blot analysis was conducted on an equal OD600 of each strain. Blots were probed with α-CtrA primary antibody and HRP-
conjugated goat anti-rabbit secondary antibody (Biorad) and the signal detected with the Supersignal Pico substrate (Pierce). YB3558
demonstrates significantly reduced CtrA abundance, while complementation with ctrA under native control (YB3559) restores CtrA to near
wild-type levels.
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in CB15 and YB3558.
Plasmids bearing transcriptional lacZ fusions were in-
troduced into both wild type and YB3558 strains. The pro-
moters for the reporter constructs were ctrA (pctrA290,
[9]), ctrA P1 (pctrA-P1, [9]) ctrA P2 (pctrA-P2, [9]), ftsZ
(plac290/HB2.0BP, [18]), ftsQA (pMSP8LC, [19]), ccrM
(pCS148, [20]), fliQ (pWZ162, [21]) and pilA (pJS70, [22])
as well as lacZ under the control of a xylose inducible pro-
moter to serve as a negative control (pCS225, [23]). Expo-
nential phase cultures were assayed for β-galactosidase
activity (Figure 7). Total transcriptional activity from thectrA promoter was unaffected, though there was a reduc-
tion of activity from the weak P1 promoter, but not the
stronger P2. Activity from these promoters is dependent
upon many factors, one of them being CtrA protein abun-
dance. It is possible that even though CtrA abundance in
YB3558 is severely reduced, it is more than enough to ac-
tivate the P2 promoter.
ftsZ and ftsQA promoters had a moderate reduction in
activity, and the ccrM promoter had a slight reduction in
activity. These genes are essential for viability. The mod-
erate reduction in transcription for these genes agrees
with the hypothesis that genes involved in essential cell
Figure 7 Expression of CtrA-dependent promoters in wild-type and YB3558 strains. β-galactosidase assays were performed on
exponentially growing cultures as described in the Methods. CtrA-dependent promoters of essential cell process genes show
little-to-no change between wild-type and YB3558, while the pilA promoter shows a drastic difference in expression between the strains.
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duction in CtrA in YB3558. In contrast, the pilA pro-
moter exhibited a drastic decrease in activity, as would
be expected given the selection by which this mutant
was obtained. However, activity from the fliQ promoter
(fliQ is a flagellar biosynthesis gene and not essential)
was largely unaffected. It is not clear why this promoter
is unaffected while the pilA promoter shows such a dif-
ference in activity. It could be that the pilA promoter is
much more sensitive to CtrA levels.
Regulation of pilA is controlled not only by CtrA, but by
SciP. SciP interacts with CtrA to prevent transcription of
genes positively regulated by CtrA, such as pilA, in
swarmer and late predivisional cells [24]. It is possible that
the dramatic decrease in pilA promoter activity in YB3558
is not from CtrA abundance itself, but an indirect effect of
reduced CtrA abundance leading to increased SciP activ-
ity. However, CtrA positively regulates transcription of
sciP and the strong reduction of CtrA activity in the
YB3558 mutant should lead to a decrease in SciP levels,
not an increase. In agreement with this hypothesis it has
been shown that a site-directed mutation that abolishes
transcription from the ctrA P1 promoter caused a
strong reduction of CtrA abundance [25], similar to that
of the YB3558 mutation in this study, and this lead to
significantly reduced expression of SciP, down to 19% of
wild-type level [25]. The ctrA P1 mutant also had mor-
phological and growth defects similar to those found here,
and several assays demonstrated that CcrM transcription
and translation was largely unaffected, agreeing with our
results. Therefore it is unlikely that the effects observedon gene expression are the result of increased SciP
activity.
Some CtrA-dependent promoters appear more resili-
ent to changes in CtrA concentration than others. It has
been shown previously that promoters that deviate from
the canonical TTAA-N7-TTAA CtrA binding site have a
lower CtrA binding affinity [26,27]. It is possible pro-
moters that are more susceptible to changes in CtrA
concentration have more divergent CtrA binding sites,
causing them to have lower CtrA affinity and thus lower
binding site occupancy at lower CtrA concentrations
such as found in YB3558. A list of CtrA binding sites
from each of the transcriptional fusions used in Figure 7
(excluding the xyl control) is shown in Table 2. The
CtrA binding region for each gene was determined ex-
perimentally by DNA footprinting (see references in
Table 2). The ctrA-P2, ccrM and fliQ reporters displayed
the least change in YB3558 compared to wild-type, indi-
cating expression from these promoters is more resilient
to changes in CtrA concentration. The ctrA-P2 site is
well characterized as TTAA-N6-TTAA with an add-
itional TTAA half site 1 bp downstream. This binding
site is relatively close to the canonical structure. The
binding sites for ccrM and fliQ are TTAA-N7-CTAA
and CTAA-N7-TTAA respectively. Each binding site dif-
fers from the canonical structure by a single base pair
substitution. Therefore, the promoters displaying little
change in YB3558 all are relatively similar to the known
CtrA binding sequence. The ctrA-P1, ftsZ, pilA and to a
lesser extent ftsQA fusions all displayed noticeable
changes in expression in YB3558 compared to wild-type.
Table 2 CtrA binding sites for CtrA-regulated genes
Gene CtrA binding site Ref.







pilA–Region 1 CTGTTTACTGGCCATTAAGTG [22]
Region 2 TGGTTAAGAACAAATAACGGTAAATACAAATAAACCA
Region 3 TGGTCAACAAAAGACTAAAAT
TTAA half sites are indicated in bold.
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site and obviously diverges greatly from the consensus
CtrA binding site. The ftsQA site is TTAA-N7-CTAA, the
same as the ccrM binding site, though ftsQA only displays
a moderate change in transcription inYB3558. However,
the ftsZ promoter region, which shows the second largest
transcriptional change in YB3558, has a perfectly canon-
ical TTAA-N7-TTAA binding site. Therefore it is unlikely
that varying promoter affinities due to divergence from
the consensus CtrA binding site can fully explain the
changes (or lack thereof) for CtrA-dependent promoters
in YB3558, though they may still contribute.
Though the genes used for analysis in this study mostly
have single CtrA-binding sites close to the consensus, the
pilA gene, which displays drastically reduced transcription
in YB3558 compared to wild-type, appears different com-
pared to the other genes presented in regards to CtrA
regulation. CtrA was shown to the bind to three distinct
regions in the pilA promoter area. Region 1 has a TTTA-
N7-TTAA binding site straddling the −35 site. Region 2, 19
bp upstream of Region 1, has two potential CtrA binding
sites, TTAA-N6-ATAA and TAAA-N6-TAAA, separated
by 3 bp. Region 3, 71 bp upstream of Region 2, has a single
TCAA-N7-CTAA binding site. Though the Region 1 bind-
ing site is relatively close to the consensus sequence, all the
other binding sites diverge greatly from the consensus in
sequence and/or half-site spacing. Clearly CtrA regulation
of pilA is more complex than that of the other genes
presented. Perhaps the divergent binding sites have low af-
finity for CtrA and the multiple weak binding sites create
cooperative CtrA binding necessary to achieve maximal
pilA expression. It would be plausible that this scenario
(multiple weak sites working together) would be quite sen-
sitive to changes in CtrA protein levels, leading to the dras-
tic reduction in transcription seen in YB35587. Further
analysis of CtrA regulation of pilA will prove informative.
Is it possible that promoters more susceptible to
changes in CtrA concentration/activity account for all thepleiotropic defects observed in podJ and pleC strains?
Current understanding of PleC’s role (and thus PodJ’s) in
developmental signaling is to regulate phosphorylation
levels of another signaling protein DivK, which in turn
regulates the activity of the CckA phosphorelay that con-
trols CtrA activation [28,29]. A pleC mutant should have
reduced CtrA levels, similar to the CtrA phenotype found
in this study. Though CtrA protein levels in pleC are simi-
lar to wild-type, there is a significant decrease in CtrA
phosphorylation [30]. Also in agreement with this hypoth-
esis, reduced CtrA levels have been implicated as contrib-
uting to the null-pili phenotype of podJ mutants [31].
However, the other polar development phenotypes are not
as well explained by CtrA-promoter effects. The known
link between CtrA and flagellar motility in C. crescentus is
that CtrA initiates the flagellum synthesis cascade [20].
The fliQ-lacZ reporter demonstrates that the synthesis
cascade is unaffected, which agrees with the fact that both
pleC and podJ mutants produce flagella. CtrA must affect
motility in a way other than synthesis of the flagellum,
possibly two ways since the flagellum is paralyzed in a
pleC mutant but capable of rotation in a podJ mutant. The
effect of CtrA on motility appears to be independent of
CtrA abundance as complementation of CtrA abundance
by pSAL14 failed to restore wild-type motility to YB3558
(Figure 1). If the effect is not dependent on CtrA abun-
dance, it may be dependent on timing of CtrA activity. Ex-
pression from the mutant promoter in YB3558 is likely
constitutive, and may lead to early induction of whatever
CtrA-dependent pathway is involved in motility other than
flagellum synthesis. However, the CckA/ChpT pathway
that controls CtrA activity should not be perturbed in this
mutant, so even though CtrA could be produced constitu-
tively, its activity should still be properly regulated. The
full link between CtrA and motility is still a mystery.
The connection between CtrA and holdfast synthesis is
also not clear. While it is known that at least some of the
holdfast synthesis genes display changes in transcription
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ments have shown that holdfast genes have altered tran-
scription in a ctrA mutant [7,33], it has also been shown
that holdfast synthesis can be stimulated in swarmer cells
when they contact a surface [34], and that developmental
holdfast synthesis is also likely regulated by cyclic-di-GMP
levels [35]. We have recently shown that the holdfast
synthesis and anchoring machineries are synthesized
and polarly localized in predivisional cells in prepar-
ation for holdfast synthesis in the next cell cycle [36,37].
Therefore, it is likely that CtrA regulates the synthesis
of the holdfast synthesis-anchoring machinery in
predivisional cells, but that the activation of this machin-
ery is regulated by surface contact and developmental sig-
nals. The additional possibility that CtrA abundance
effects post-transcriptional regulation of holdfast synthesis
cannot be ruled out. However, both effects on motility and
post-transcriptional effects on holdfast synthesis could be
downstream effects of CtrA-dependent decrease in pro-
moter activity of one or more other regulators.
Conclusions
In this study we performed a detailed mutagenesis selec-
tion/screen to identify new regulators that control mul-
tiple aspects of polar development similar to known
developmental regulators PleC and PodJ. Our results sug-
gest that potential regulators downstream of those already
known may be essential, redundant or branched. In the
process we found evidence that suggests at least some of
the pleiotrophic phenotypes are the result different affin-
ities between CtrA and CtrA-dependent promoters.
Methods
Media and growth conditions
All C. crescentus strains were grown at 30°C in peptone
yeast extract (PYE) media [38]. When appropriate, kana-
mycin (5 μg/ml liquid, 20 μg/ml solid), chloramphenicol
(0.5 μg/ml liquid or 1 μg/ml solid), tetracycline (1 μg/ml
liquid or 2 μg/ml solid) and nalidixic acid (20 μg/ml)
were used. Escherichia coli strains were grown at 37°C
in Luria-Bertani (LB) medium [39] with kanamycin (50
μg/ml), chloramphenicol (20 μg/ml liquid or 30 μg/ml
solid), ampicillin (50 μg/ml liquid or 100 μg/ml solid),
or tetracycline (12 μg/ml liquid or 12 μg/ml solid).
Transposon mutagenesis and selection of ΦCbKR mutants
The plasmid pFD1 [40], carrying the mariner transposon
and the transposase gene, was introduced into C.
crescentus strain CB15 (wild-type) by conjugation with
E. coli strain YB2028 (SM10λpir (pFD1)). Cells from five
independent conjugations were pooled and frozen at
-80°C. Aliquots of cells were thawed, mixed with undiluted
Caulobacter phage ΦCbK stock (~1010 pfu/ml), plated on




Overnight cultures of all ΦCbKR mutants were observed
with a 100× objective on a Nikon Optiphot-2 microscope.
Strains were qualitatively scored on three phenotypes:
presence of rosettes, presence of stalks, and presence of
motile swarmer cells.
Phage resistance
Strains were grown overnight, normalized to equal
OD600 and diluted to 10
0, 10-4 and 10-5. Cell dilutions
were mixed in equal volumes with ΦCbK (~1010 pfu/ml)
or plain PYE. The mixture was incubated at room temp
for 10 minutes, then 5 μl spots were placed onto PYE
plates. The plates were incubated at 30°C for 3–5 days.
Relative resistance was determined by the number and
size of colonies that appeared.
Confirmation of transposon mutant phenotypes and
identification of genes
The kanamycin marker in strains of interest were trans-
duced into C. crescentus strain CB15 with the phage
ΦCr30, using a standard transduction protocol [41].
KanR colonies were isolated and overnight liquid cul-
tures were shown to have the same phenotype as the
parent strain.
Genomic DNA was isolated using a phenol/chloroform
extraction method. Briefly, cells were grown overnight at
30°C in 3 ml PYE + kanamycin. The entire culture was
pelleted by centrifugation, and resuspended in cold TE pH
7.5 to a final volume of 500 μl. Lysozyme (Sigma) and
RNAse (Amresco) were added to final concentrations of
1 mg/ml and 0.1 mg/ml respectively, and the mixture was
incubated at 37°C for 30 min before adding 0.1 volumes of
10% w/v SDS. Proteinase K (Amresco) was added to a final
concentration of 1 mg/ml. The solution was mixed gently
and incubated at 50°C for 2 hours with occasional mixing.
50 μl of sodium chloride (5 M) was added, and the DNA
was extracted 3–4 times with one volume of phenol/
chloroform/isoamyl alcohol (25:24:1), followed by two ex-
tractions with one volume of chloroform. After extraction,
DNA was precipitated with 0.6 volumes of isopropanol,
washed twice with 70% v/v ethanol, allowed to dry, and
resuspended in 50 μl dH2O.
Southern blot analysis
In order to identify mutants with insertions in podJ and
pleC, Southern blot analysis was used to analyze the posi-
tions of the mariner insertions in mutants with pheno-
types similar to podJ and pleC. Probes were prepared with
DIG-High Prime DNA Labeling and Detection Starter Kit
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CB15 genomic DNA using primers 5podJ2508 and
3podJ4522 (Table 3) and probed against SfiI-digested
chromosomal DNA. A 2.9 kb pleC probe was PCR ampli-
fied from CB15 genomic DNA using primers pleCfor and
pleCrev (Table 3) and probed against XhoI-digested
chromosomal DNA.
For strains of interest that did not have insertions in podJ
or pleC, genomic DNA (~3 μg) was digested with PstI and
separated on an agarose gel. DNA was excised from the gel
area found to include the band seen by Southern analysis
using a probe for the kanamycin resistance gene. The DNA
was isolated from the gel using the Qiaquick Gel
Extraction kit (Qiagen) and ligated to PstI-digested pKSII+
(Stratagene) overnight at 16°C. The ligation was
electroporated into E. coli strain DH5α (F’, ϕ80dlac-
ZΔM15, Δ(lacZYA-argF)U169, endA1, recA1, hsdR17 (rk-,
mk+), deoR, thi-1, supE44, λ-, gyrA96, relA1). AmpR KanR
colonies were isolated, and plasmid DNA was purified.
DNA sequencing
Plasmids were sequenced with primer MarRseq (Table 3)
using Big Dye version 3.1 (Applied Biosystems), and run
on an ABI3730 DNA Analyzer at the Indiana Molecular
Biology Institute (Indiana University). The transposon in-
sertion site was identified in the sequence, and the gene
was identified by a Basic Local Alignment Search Tool





Characterization of the YB3558 mutant
Visual analysis
Cultures of YB3558 were grown overnight in PYE with
kanamycin, diluted to an OD600 of approximately 0.15, and
allowed to grow to an OD600 of 0.5-0.6, then observed
using 100X Plan Apo objective on a Nikon Eclipse E800










CtrAlacUp CAGAACGCCGGAATTCCGTCCGTGAInstruments 1317 cooled CCD camera and processed with
Metamorph v. 4.5 (Universal Imaging Corporation). Stain-
ing of holdfast with fluorescein isothiocyanate-wheat germ
agglutinin (FITC-WGA) was performed as described previ-
ously [32]. Fluorescence was observed on the Nikon E800
and images were processed using Metamorph.Growth curves
Strains were grown overnight in PYE supplemented with
appropriate antibiotics and diluted to an OD600 of 0.1 in
fresh PYE with no antibiotic. They were allowed to grow
for two doublings (to OD600 of ~0.4) and diluted again to
an OD600 of 0.05 in 10 ml of PYE. 100 μl of the culture
was removed and its OD600 recorded every 30 minutes for
5 hours.Swarm assay
Strains were grown overnight in PYE supplemented with
appropriate antibiotics, diluted to an OD600 of 0.1, and
allowed to grow for two doublings (to OD600 of ~0.4).
All strains were diluted to an equal OD600 and 1 μl of
the culture was injected into a 0.3% Agar PYE plate.
This was incubated at room temperature for 5–7 days in
a humid container.Complementation
Plasmid pSAL14 [17], carrying a wild-type copy of the
ctrA gene, was transformed into YB3558. The resulting
strain, YB3559, was assayed for complementation of the
phenotypes seen in YB3558.Western analysis
To examine levels of CtrA in mixed culture, exponen-
tially growing cells were collected and resuspended to
equal OD600 in a final volume of 100 μl in 1X SDS load-
ing buffer (62.5 mM Tris–HCl pH 6.8, 10% v/v glycerol,
2% w/v SDS, 0.05% v/v β-mercaptoethanol, 0.0025% w/v
Bromophenol blue). 15 μl of this sample was separated
on a 10% SDS-polyacrylamide gel and transferred to a
nitrocellulose membrane. The membrane was probed
with α-CtrA serum [42] at 1:10,000 dilution. The mem-
brane was then probed with HRP-conjugated goat
anti-rabbit secondary antibody (Biorad) at 1:20,000, de-
veloped using Supersignal Pico (Pierce) and imaged on a
Kodak imagestation 440CF. For quantification of CtrA
levels in wild-type and mutant strains, four replicates of
each sample were loaded on one gel and treated as de-
scribed above. Once exposed, Kodak Molecular Imaging
Software version 4.0.3 was used to quantify the intensity
of each band and band intensities were averaged for
wild-type and mutant.
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The ctrAP2::Mn promoter was PCR amplified using the
primers M134UP and M134DN (Table 3), incorporating
EcoRI and XbaI restriction sites, respectively. The wild-type
promoter was amplified using the primers M134DN and
CtrAlacUp (Table 3). The digested fragments containing
the promoter regions were cloned into the lacZ containing
plasmid pLac290 [43].
β-Galactosidase assay
Plasmids carrying promoter fusions to lacZ were trans-
ferred to YB3558 and CB15 by conjugal mating. The
resulting transformants were grown to an OD600 of 0.4
to 0.6 in liquid PYE supplemented with tetracycline.
Cells were added to three tubes containing Z-buffer (60
mM sodium phosphate (dibasic), 40 mM sodium phos-
phate (monobasic), pH 7.0, 10 mM potassium chloride,
1 mM magnesium sulfate, 50 mM β-mercaptoethanol)
to a final volume of 800 μl, and 25 μl 0.1% w/v SDS was
added. To assay the LacZ activity in the samples, 200 μl of
2-nitrophenyl β-D-galactopyranoside (ONPG) (4 mg/ml
in 0.1 M potassium phosphate buffer, pH 7.0) was added
to each sample, and reactions were stopped by the
addition of 400 μl 1 M sodium carbonate. The time be-
tween addition of ONPG and stopping the reaction was
recorded. Samples were centrifuged for 5 minutes to pellet
cells and debris, then the absorbance at 420 nm (A420) of
each sample was measured and recorded. β-galactosidase
activity was calculated using the formula (A420 × 1000)/
(OD600 × time (min) × volume of cells used (ml)).
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